6M

Ambea AB (publ)FRA Ambea AB Stock Report

Last reporting period 30 Jun, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

0.757

Micro

Exchange

XFRA - Deutsche Boerse AG

6MA.F Stock Analysis

6M

Avoid

Based on Eyestock quantitative analysis, 6MA.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

43/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-5.5 %

Overvalued

Market cap $B

0.757

Dividend yield

2.24 %

Shares outstanding

89.861 B

Ambea AB engages in the provision of elderly care, disability care, and staffing. The company is headquartered in Solna, Stockholm. The company went IPO on 2017-03-31. The Ambea group offers accommodation, support, training and staffing within health and social care. The Group has over 450 units throughout Sweden and in Norway. The Swedish operations comprise the brands Vardaga, Lara and Bemanning. Among other brands, there are Rent a Doctor, Rent a Nurse, Rent a Socionom and Careteam, as well as BoA Mellanvard. The Norwegian operations comprise support and residential care in disabilities and psychiatry through the companies Heimta and Vitale. The Company’s main shareholders are ACTR Holding Ab and Actor General Partner SARL Sweden SCA. The company operates Malrettet Intervensjon AS, Elevhalsan, Stod och Resurs AB and Tiltaksgruppa fokus as subsidiaries.

View Section: Eyestock Rating